The glomerular filtration barrier is known as a "size cut-off" slit to retain nanoparticles or proteins larger than 6~8 nm in the body, and to rapidly excrete the smaller ones through the kidneys. However, in a sub-nm size regime, we found that this barrier behaved as an atomically precise "bandpass" filter to significantly slow down renal clearance of few-atom gold nanoclusters (AuNCs) with the same surface ligands but different sizes (Au 18 , Au 15 and Au 10-11 ). Compared to Au 25 (~1.0 nm), just few-atom decreases in the size resulted in 4~9 times reductions in the renal clearance efficiency in the early elimination stage because the smaller AuNCs were more readily trapped by the glomerular glycocalyx than the larger ones. This unique in vivo nano-bio interaction in the sub-nm regime also slows down the extravasation of sub-nm AuNCs from normal blood vessels and enhances their passive targeting to cancerous tissues through enhanced permeability and retention effect. This discovery highlights the size precision in the body's response to nanoparticles and opens a new pathway to develop nanomedicines for many diseases associated with glycocalyx dysfunction.
engineered NPs with sizes below 6 nm, they can be readily eliminated through the kidneys by crossing a unique multiple-layer structure of glomeruli 12, 13 . For instance, Choi et al. developed a class of zwitterionic quantum dots (Qdots) and found that Qdots with hydrodynamic diameters (HDs) below 6 nm cleared out of the body through the urinary system much more efficiently than the larger ones: the renal clearance efficiency of Qdots increased from 45 %ID to 75 %ID (4 h post injection) with a just slight decrease of HDs from 5.64 nm to 4.64 nm 14 . A similar trend was also observed in renal clearable silica NPs 15 : a decrease of HD from 6 nm to 3.3 nm resulted in a significant increase of renal clearance efficiency from 55 %ID to 67.5 %ID (24 h post injection). We also developed renal clearable (AuNPs) with HDs of 3.0 nm 16 and 2.2 nm 17 , which were eliminated out of the body at an efficiency of 43 and 53 %ID (24 h post injection), respectively. These studies are also consistent with a general observation of protein filtration through the glomeruli, where the smaller proteins such as 5.3 nm ScFv can be eliminated out of the body at an efficiency 7 times higher than those larger ones 14 . Moreover, the smaller 3.0 nm inulin is nearly 30% more efficient than 3.4 nm myoglobin in renal clearance 14 . With these findings, it has been generally accepted that the glomeruli serve as a one-directional "size cut-off" slit, where engineered NPs or proteins with the sizes smaller than 6 nm can pass through the kidneys and the smaller ones more efficiently clear out of the body than the larger ones.
Since size-dependent glomerular filtration is mainly observed from engineered NPs or proteins with sizes ranging from 2 nm to 6 nm. A fundamental question emerges: is this size-dependency in the glomerular filtration still valid at an even smaller size scale? Investigation of how the glomeruli filtrate out engineered NPs in the sub-nanometer (subnm) regime not only helps gain more comprehensive understandings of the glomerular filtration and kidney diseases in general but is also fundamental importance of precise control of nanomedicines that can break into much smaller fragments in vivo. Here, we reported that in a sub-nm size range (~1 nm), the glomerulus is no longer a "size cut-off" slit 18 but can become an atomically precise "bandpass" barrier to significantly slow down renal clearance of sub-nm gold nanoclusters (sub-nm AuNCs). In the sub-nm regime, renal clearance of AuNCs exponentially increases with an increase of the number of atoms in the particle. Unlike the size-dependency observed in the glomerular filtration of engineered NPs larger than 2 nm, which was mainly dictated by the pore size of glomerular basement membrane (GBM) and podocyte 19 , the inverse size-dependency in the glomerular filtration in the sub-nm regime originated from a discovery that the smaller sub-nm AuNPs are more easily and physically retained by the endothelial glycocalyx of the glomerulus
Atomically precise glutathione-coated gold nanoclusters
The observation of size-dependency in the glomerular filtration in the sub-nm size regime was made possible by a recent breakthrough in the precise control of the number of gold atoms in sub-nm AuNCs [20] [21] [22] [23] . Atomically precise AuNCs coated with glutathione (GSH) were synthesized by controlling reduction kinetics of gold ions in the presence of glutathione in aqueous solutions based on reported method 24 Supplementary Fig. 1 ). While these AuNCs are slightly different in the numbers of glutathione ligands on the particles, our recent studies have shown a 50% difference in the number of glutathione ligands on 2.5 nm AuNPs have little effect on their renal clearance efficiencies 25 . Moreover, a pharmacokinetics study of Au 22 SG 18 and Au 22 SG 16 further shows that a slight difference in the number of GS ligand induces little differences in blood retention and clearance of sub-nm AuNCs (Supplementary Fig. 2 and 3 ). All these results are consistent with the previous observation of renal clearance of a class of cysteine coated Qdots, where their sizes rather than the number of cysteine ligands govern their renal clearance efficiencies 14 . We specifically used glutathione to stabilize ultrasmall AuNCs because zwitterionic glutathione can effectively minimize adsorption of the AuNPs to serum protein 17, 26 . Similarly, these ultrasmall glutathione coated AuNCs are also highly resistant to the adsorption of serum protein and blood cells ( Supplementary Fig. 4 and 5); thus they can retain their original sizes in native physiological environment and allow us to quantitatively correlate renal clearance, pharmacokinetics as well as tumour targeting with their original sizes without interference from serum protein and blood cells during the circulation. In addition, among these ultrasmall clusters, Au 25 and Au 18 give near-infrared (NIR) emissions ( Supplementary Fig. 6 ), which allows us to in-situ fluorescently image the interactions of Au 25 and Au 18 with the endothelium of normal blood vessels.
Renal clearance of gold nanoclusters
Strong X-ray absorption cross section of gold atom offers a unique opportunity to noninvasively image renal clearance of these ultrasmall AuNCs. We selected three AuNCs, Au [10] [11] , Au 18 and Au 25 , with a 7-atom difference in size, for X-ray imaging studies. As shown in Supplementary Movie 1, Au 25 was rapidly eliminated through the kidneys, renal elimination of Au 18 was slow and renal clearance of Au 10-11 was even slower. At 40 min post injection (p.i.), much more Au [10] [11] and Au 18 were retained in the kidneys than Au 25 ( Fig. 1a) and the ratio of bladder to kidney derived from X-ray imaging was 2.32±0.25, 1.87±0.46 and 1.06±0.30 for Au 25 , Au 18 and Au [10] [11] (Fig. 1b) , respectively. Since these AuNCs are highly physiologically stable and resistant to serum protein adsorption for both short (30 min.) and long period (24 hrs) ( Supplementary Fig. 4 and 7) , the observed differences in bladder/kidney ratios clearly indicate that the kidney filtration is highly sensitive to the cluster size in the sub-nm regime. In order to more quantitatively understand renal clearance of these atomically precise AuNCs, BALB/C mice were intravenously injected with 100 μL phosphate buffered saline (PBS) containing Au 25 , Au 18 , Au 15 and Au [10] [11] , respectively at the same molar concentration of 100 μmol/L, followed by quantification of the Au amount in urine with inductively coupled plasma-mass spectrometry (ICP-MS) at 2, 5, 8, 12 and 24 h post injection (p.i.). Consistent with X-ray imaging studies, renal clearance of sub-nm AuNCs was highly sensitive to the number of Au atoms (Fig. 1c 17 (Au 8856 , 24 hr p.i.) were renally cleared. Combining these results clearly shows an inverse size-dependency in renal clearance of AuNCs in the sub-nm region, distinct from the prevailing understanding that the smaller NPs always more rapidly clear through the urinary system than larger NPs 14, 15 . This indicates that the glomerulus (Fig. 1e) , composed of glycocalyx, endothelial cells, glomerular basement membrane and podocyte, 12, 27 is no longer a one-directional "size-cut-off" slit 18 but becomes an atomically precise "bandpass" barrier to significantly slow down renal clearance of ultrasmall AuNPs with sizes in sub-nm regime (Fig. 1d) .
Glomerular filtration of Au 18 and Au 25
Since renal clearance is fundamentally governed by the glomerular filtration barrier, in order to unravel the origin of the observed size-dependent clearance in sub-nm regime, we investigated interactions of two representative AuNCs, Au 18 and Au 25 , with the glomeruli using electron microscope (EM) because these two AuNCs only have a 7-atom difference in size but exhibit a 4-time difference in renal clearance 2 hr p.i.. Since these AuNCs were too small to be directly revealed with EM, we applied silver staining 28 to increase their sizes and contrast. As shown in Supplementary Fig. 8 , both Au 18 and Au 25 can catalyse the deposition of metallic silver on their surface, resulting in formation of larger hybrid silver-gold NPs in the glomerular arterioles and peritubular capillaries (yellow line) while no silver NPs were observed from the silver-stained glomerular tissues of the mouse without injection of AuNCs (Control). To unravel the differences of the nano-bio interactions between Au 18 and Au 25 in vivo, and avoid the interference from the AuNCs in the blood, we perfused the glomeruli with saline to remove those clusters that have weak interactions with the glomeruli in the blood, followed by tissue fixation with 4% paraformaldehyde/PBS. As shown in Fig.  2 , all the fine structures of the glomeruli were observed, including endothelium (endothelial glycocalyx and endothelial cell), glomerular basement membrane, podocytes and glycocalyx layers. While no any silver NPs were observed from the control glomeruli after silver staining (Fig. 2a) and only few large silver-enhanced Au 25 were found in the glomeruli of the mice injected with Au 25 (Fig. 2b) , a large number of monodispersed silver-enhanced Au 18 were retained on the glycocalyx of endothelium and podocytes ( Fig. 2c and Supplementary Fig. 9 ).
To unravel whether the long retention of Au 18 on the glycocalyx is involved in any chemical interactions or not, we incubated Au 18 with heparan sulfate proteoglycan, a major component of the glycocalyx layer 12, 29 for more than 24 hrs. As control, Au 25 clusters were also investigated under the same condition. As shown in Supplementary Fig. 10 , very little binding of Au 18 and Au 25 to heparan sulfate proteoglycan were observed, implying that the retention of smaller Au 18 on the glycocalyx was not due to any specific chemical interactions. In addition, very few Au 18 and Au 25 were found in the glomeruli 7 days p.i. at the tissue-level ( Supplementary Fig. 11 ), further suggesting that both clusters were eventually filtered through the glomerular compartments without involvement of any specific cellular uptake. Therefore, the slow renal clearance of Au 18 over Au 25 is very likely because Au 18 was physically retained on the glycocalyx for a longer period than Au 25 , very similar to the inverse size-dependency observed in gel filtration or size-exclusion chromatography 30 : larger molecules/particles will be filtrated faster than smaller ones because the smaller ones are physically retained by stationary materials for a longer period. (Fig. 2d) . These results also imply that potential pore sizes on the glycocalyx can be smaller than 1nm; as a result, they can retain sub-nm AuNCs for long periods of time.
Normal vessel extravasation and pharmacokinetics
As a major component of the glomerulus, the glycocalyx also lines normal blood vessels 31, 32 ; thus, the long retention of Au 18 on the endothelial glycocalyx observed in the glomeruli might also affect their extravasation from the normal blood vessels. By taking advantages of NIR emission from both Au 18 and Au 25 , we noninvasively imaged the extravasation of these two AuNCs from normal blood vessels to the interstitial tissue space in ears. As shown in Fig. 3a and Supplementary Movie 2 and 3, right after the intravenous injection, both of Au 18 and Au 25 were immediately transported to the artery, followed by a gradual increase in fluorescence intensities of the tissue interstitial space. We used the ratio of (interstitial intensity-background intensity) / (artery intensity-background intensity) to quantify the differences in extravasation between these two different AuNCs (Au 18 and Au 25 ). As shown in Fig. 3b , it took 2.7 min for Au 25 to reach an equivalent intensity between the tissue interstitial space and artery while the intensity of Au 18 in the tissue interstitial space is only 37% of that in artery during the same period. This difference clearly indicates that it is more difficult for Au 18 to cross the blood vessel walls than Au 25 (Fig. 3c) , consistent with the observation of the slow glomerular filtration of Au 18 over Au 25 .
While other smaller sized AuNCs are not luminescent and their interactions with the blood vessels were hardly imaged with fluorescence microscope like Au 18 and Au 25 , combination of the observed size-dependent renal clearance and the slow extravasation of smaller Au 18 imply that other smaller AuNCs might also have longer blood retention and elimination halflives. By quantifying their blood pharmacokinetics (Fig. 3d, Supplementary Table 3 ), we were able to obtain more quantitative nano-bio interactions in vivo in this sub-nm regime.
As shown in Fig. 3d , the smallest Au 10-11 exhibited the longest blood retention, followed by Au 15 , Au 18 and Au 25 . At 2 min. p.i., the blood concentration of AuNCs linearly decreased from 28.45, to 25.51, 19.37, 12.13 %ID/g while the volume of distribution (Vd 33 , a parameter that reflects the extent of NPs in extravascular tissues) linearly increased from 3.30 to 3.84, 4.55 and 6.07 mL with the number of atoms increased from 11 to 15, 18 to 25, respectively (Fig. 3e, Supplementary Table 4) , consistent with the different extravasation kinetics of Au 18 and Au 25 from the fluorescence imaging studies. On the other hand, clearance (CL) 33 , a parameter to measure the efficiency of the body in eliminating the particles through the urinary system, exponentially increased from 0.41, 0.50, 0.71 to 2.04 mL/h and the elimination half-life (t 1/2β ) of AuNCs exponentially decreased from 5.65, 5.31, 4.47 to 2.09 hr with an increase of the number of atoms from 11, 15, 18 to 25, respectively (Fig. 3f, Supplementary Table 4) . Consistency among these studies of the urine excretion, glycocalyx retention, extravasation and pharmacokinetics of these sub-nm AuNCs clearly points out that in vivo behaviours of sub-nm AuNCs are highly size-dependent: the smaller sized AuNCs have longer the blood retention and slower extravasation and glomerular filtration.
Passive tumour targeting of gold nanoclusters
Not limited to glomerular filtration and extravasation from normal tissues, the passive tumour targeting of sub-nm AuNCs is also size-dependent. Using the nude mice bearing MCF-7 breast xenografts as model, we quantified the tumour targeting efficiencies of these AuNCs 24 h p.i., which were 8.17 ± 0.23 %ID/g, 6.07 ± 1.18 %ID/g, 5.27 ± 0.23 %ID/g and 2.28 ± 0.13 %ID/g, for Au 10-11 , Au 15 , Au 18 and Au 25 , respectively (Fig. 4a , other organs accumulation in Supplementary Fig. 12 ). These results clearly indicate that the efficiency of passive tumour targeting in the sub-nm regime linearly decreased with the increase of the number of Au atoms in the clusters. Once the sizes of AuNPs became larger than Au 25 , this linear relationship vanished; instead, the tumour uptake of ~1.7 nm GS-AuNPs (Au 201 , ~1.97 %ID/g) and ~2.5 nm GS-AuNPs (Au 640 , ~2.00 %ID/g) became comparable to that of Au 25 (2.28 %ID/g). To unravel the origin of the observed size-dependent tumour targeting of sub-nm AuNCs, we correlated tumour targeting efficiency with blood retention (area under pharmacokinetics curve, AUC). The linear relationship between the targeting efficiency and AUC (Fig. 4b) indicates that the size-dependent tumour targeting in the sub-nm regime is fundamentally due to size-dependent blood retention of sub-nm AuNCs: the smallest AuNCs, Au [10] [11] , has the longest retention in the blood; as a result, they have the highest accumulation in tumours. Since tumour/blood ratios of all the sub-nm AuNCs are all larger than 1 and much higher than muscle/blood ratios at 24 hr p.i. (Fig. 4c) , the selective accumulation of sub-nm AuNCs is fundamentally because of the enhanced permeability and retention (EPR) effect 34 : leaky and dense vasculature leading to long-retention of nano sized particles in tumours. Further investigation of distribution of Au 18 and Au 25 in tumours 24 hr p.i. (Fig. 4d) confirms that both AuNCs crossed the leaky tumour vasculature and entered tumour microenvironment. More importantly, because Au 18 has much longer blood retention than Au 25 , more Au 18 clusters were retained in tumour microenvironment than Au 25 clusters, consistent with the observed size-dependent tumour targeting in the sub-nm regime. Combination of these results with our previous observation of passive tumour targeting of 2.5 nm renal clearable AuNPs 26, 35 confirms that the EPR effect is indeed retained in renal clearable AuNPs with size down to few atoms, which could further broaden EPR effect, a major strategy used by large non-renal clearable NPs in the tumour targeting 5 .
Different from tumour/blood ratios, the ratios of the liver, spleen and intestine to the blood at 24 hrs. p.i. were all close to 1 (Fig. 4e) , suggesting that these ultrasmall AuNCs have little interactions with those RES organs. On the other hand, the ratio of the kidney to the blood was much larger than 1 (Fig. 4e) and the kidney accumulation of these AuNCs continually decreased over time ( Supplementary Fig. 13 ), clearly indicating that the kidneys remain the major organ for eliminating these ultrasmall AuNCs. After one month, the major organs accumulation of different-sized AuNCs decreased to 1.5 %ID (Fig. 4f, Supplementary Fig.  14) , suggesting that all these AuNCs were gradually eliminated from the body through the urinary system. In summary, by investigating in vivo behaviours of sub-nm AuNCs with high resistance to the binding of serum protein and blood cells, we discovered that the glomeruli can serve as an atomically precise barrier to slow down the renal clearance of the clusters with size below 1 nm: a few-atom decrease in the cluster size results in a nearly one order reduction in renal clearance. This "surprising" observation fundamentally originates from the fact that the smaller AuNCs are more easily and physically retained by the glycocalyx of the glomeruli, similar to the separation principle used in gel filtration or size-exclusion chromatography. Such size-dependent interaction between sub-nm AuNCs and the glycocalyx also dictates the extravasation of sub-nm AuNCs from normal blood vessels and significantly impacts their accumulation in cancerous tissues through EPR effect. This discovery highlights how precisely the glomerulus and the body could response to ultrasmall AuNPs, which might be generalized to many other renal clearable nanosystems 14, 15, 36 and further improve our comprehensive understandings of the glomerular filtration in the sub-nm regime. Considering the similarity of rodents and human in the pore sizes of glomerular filtration membrane (Supplementary Table S1 ), these findings will also open a new pathway to design clinically translatable precision nanomedicines that can target many endothelial-dysfunction associated diseases such as strokes, atherosclerosis, hypertension, chronic renal failure once the biocompatibility of these renal clearable smaller AuNCs is fully investigated.
Method Materials and equipment
Hydrogen tetrachloroaurate used for the synthesis of gold nanoclusters was obtained from Fisher Scientific (U.S.). All the other chemicals were obtained from Sigma-Aldrich and used as received unless specified. The gold in urine, blood and each organ was detected by Agilent 7900 inductively coupled plasma mass spectrometry (ICP-MS). The luminescence spectra of Au 18 (Birmingham, NJ) . The blood-vessel images were taken with IX-71 microscope (Olympus). Optical images of kidneys and tumours were taken with IX-71 microscope (Olympus). Electron microscopic (EM) images of the kidney were recorded with a 120 kV Tecnai G 2 spirit transmission electron microscope (FEI) equipped with a LaB 6 source. The animal studies were performed according to the guidelines of the University of Texas System Institutional Animal Care and Use Committee. The female BALB/c mice (BALB/cAnNCr, strain code is 047) of 6-8 weeks old, weighing 20~25 g, were purchased from Envigo. The female nude mice (Athymic NCr-nu/nu, strain code is 069) of 6-8 weeks old, weighing 20-25 g, were also purchased from Envigo for tumour targeting study. All of these mice were randomly allocated and four-group-housed per ventilated cage under standard environmental conditions (23±1°C, 50±5% humidity and a 12/12 h light/dark cycle) with free access to water and standard laboratory food.
Synthesis of glutathione-coated gold nanoclusters
The gold nanoclusters were synthesized according to previously reported procedures with slight modifications [37] [38] [39] [40] [41] [42] . The Au 10-11 SG 10-11 and Au 15 SG 13 nanoclusters were synthesized using carbon monoxide (CO) as a reducing agent under a controlled pH condition. 37 Briefly, aqueous solutions of HAuCl 4 ·3H 2 O (6.25 mL, 20 mM) and glutathione (GSH, 5 mL, 50 mM) were added to 114 mL water. This reaction mixture was stirred vigorously for 2 minutes, followed by adjusting pH to 7 and 9 with 1 M sodium hydroxide for the synthesis of Au 10-11 SG 10-11 and Au 15 SG 13 , respectively. CO gas was bubbled through the mixture at one atmospheric pressure to reduce Au(I)-SG for 3-4 minutes. The reaction flasks were then sealed and the solutions were stirred for 24 h at room temperature.
Synthesis of Au 18 SG 14 38 : aqueous solutions of HAuCl 4 ·3H 2 O (2 mL, 10 mM) and glutathione (3 mL, 20 mM) were added to 15 mL water and stirred vigorously for 5 minutes. Then, a solution of borane tert-butylamine in toluene (20 mL, 10 mM) was added to the above mixture and the reaction mixture was stirred overnight (~16 h). After completion of the reaction, the aqueous phase was concentrated under a reduced pressure, followed by precipitation of the crude cluster product with excess methanol. 4 (0.2 M, 12.5 mL) was added into the mixture, after which this mixture was stirred at 1600 rpm for 60 min. The resulting precipitate was washed with methanol repeatedly and purified with NAP-5 column in water to remove the impurities. The as-synthesized Au nanoclusters were separated using polyacrylamide gel electrophoresis.
Stability test of the AuNCs in the physiological environment
To test whether these AuNCs bind to serum protein or not, the Au 
Blood-cell binding test
The whole blood was collected from female BALB/c mice (6-8 weeks, 20-25 g) and then stored in an anti-coagulation BD Vacutainer. This blood was divided into 4×3 groups for incubation with Au 10-11 SG 10-11 , Au 15 SG 13 , Au 18 SG 14 , Au 25 SG 18 at a 10% v/v ratio at room temperature for 30 min, followed by being centrifuged at room temperature at 500g to separate the plasma and blood cells. Finally, the amounts of gold in plasma and blood cells were quantified using ICP-MS.
X-ray kidney images of the mice after intravenous injection of Au 10-11 , Au 18 and Au 25
All X-ray images of kidneys were taken using Bruker In-vivo Xtreme Imaging. Parameters: (n=3), respectively (~100 μmol/L, 100 μL) and then placed in metabolism cages. Mouse urine was collected at 2 h, 5 h, 8 h, 12 h, and 24 h post injection. Then, the urine was completely lysed in freshly made aqua regia in plastic centrifuge tube (15 mL) for 2 days, then diluted to 10 mL using ultrapure water. All of above samples were centrifuged at 4500 rpm, 5 min and analyzed by ICP-MS.
Optical kidney images of the mice after injection of Au 18 SG 14 and Au 25 SG 18
Au 18 SG 14 and Au 25 SG 18 of 300 μL (~0.7 mmol/L) as well as 300 μL PBS (control) were iv injected into the mice, respectively. The mice were sacrificed at 10 min and 7 days p.i., and kidneys were then harvested and fixed by 4% formalin, followed by dehydration and paraffin embedding. The fixed kidneys were then sectioned into 4 μm slices. To image these ultrasmall gold clusters under bright-field optical microscopes, the silver staining was used to enhance their sizes and contrast. Before silver staining, these slices were dewaxed using xylene and then dried in lab oven at 65 °C. Each kidney slice was incubated in the silver staining solution containing 40 μL 0.1 M silver nitrate, 40 μL 0.2 g/L hydroquinone for 30 min. These silver-stained slices were then washed with ultrapure water and dried in lab oven at 65 °C again. These final samples were imaged with an IX71 optical microscope in a bright-field mode.
Electron microscopic images of the glomerulus of the mice after intravenous injection of Au 18 SG 14 and Au 25 SG 18
Firstly, the mice were sacrificed and fixed via transcardial perfusion at 10-min time point after i.v. injection of Au 25 SG 18 (~0.7 mmol/L, 300 μL), Au 18 SG 14 (~0.7 mmol/L, 300 μL) and PBS (300 μL, control), respectively. Briefly, 10 mL heparizinzed normal saline as initial perfusant was used to remove the whole-body blood under the perfusion speed of 75 mL/h, then 10 mL 4% paraformaldehyde/PBS fixative as second perfusant was injected to fix the whole animals at the same perfusion speed. After fixation perfusion, the kidneys were collected and cut into pieces of 1 mm 3 , which then were immersed in 4% paraformaldehyde/PBS in scintillation vials. Fixation was continued by immersion with agitation at 4 °C for 24-72 h. Secondly, these kidneys were then rinsed with 0.1 M sodium cacodylate buffer and post-fixed with 1% osmium tetroxide and 0.8 % potassium ferricyanide in 0.1 M sodium cacodylate buffer for one and a half hours at room temperature, followed by being rinsed with water and en bloc stained with 4% uranyl acetate in 50% ethanol for two hours. The kidney tissues were then dehydrated with increasing concentrations of ethanol, transitioned into resin with propylene oxide, infiltrated with Embed-812 resin and polymerized in a 60 °C oven overnight. Thirdly, the blocks were sectioned with a diamond knife (Diatome) on a Leica Ultracut 6 ultramicrotome (Leica Microsystems) and collected onto grids, followed by the silver-staining with the same method described above. Finally, EM images were taken using a Tecnai G 2 spirit transmission electron microscope.
Glycocalyx-binding test of Au 18 SG 14 and Au 25 SG 18
To test whether these AuNCs chemically bind to the glycocalyx, we incubated Au 18 SG 14 and Au 25 SG 18 with 10% (v/v) major component of glycocalyx-heparan sulfate (HS) proteoglycan from Sigma-Aldrich in PBS at 37 °C for 30 min and 24 h, respectively. In order to identify the colorless HS proteoglycan band, HS proteoglycan incubated-Au 18 SG 14 , Au 25 SG 18 were stained by 10% (v/v) Coomassie brilliant blue 250 (CBB 250). All these samples were analyzed by 2% agarose gel electrophoresis using the Mini-sub cell GT Gel electrophoresis system (Bio-Rad Laboratories INc.). The amount of gold in each band was quantified using ICP-MS.
In-situ blood-vessel imaging
The BALB/c mice were placed on the imaging station of an IX-71 microscope (Olympus) under isoflurane anesthesia after the removal of ear hair. The bright field images of blood vessels in ear were taken with a 10 x objective and Photon Max 512 CCD camera (Princeton Instruments , and 24 h and 48 h p.i.. The blood samples were weighted and completely lysed in 1 mL freshly made aqua regia in screw capped glass bottles (10 mL) for 3 days. They were then diluted into 10 mL using ultrapure water and transferred into 15 mL plastic centrifuge tube, centrifuged at 4500 rpm for 5 min to remove insoluble components. The final samples were analyzed with ICP-MS. 18 (~100 μmol/L, 100 μL) were intravenously injected into MCF-7 tumour bearing nude mice (n=3), respectively. These tumours were collected and weighed after 24 h post injection. The amount of gold in the tumour tissues (% injection dose/g, % ID/g) were determined using ICP-MS.
Tumour-targeting efficiency study

Biodistribution study
To quantify the distributions of Au 18 (~100 μmol/L, 100 μL) respectively (n=3). Then major organs and tissues were collected and measured by ICP-MS to detect gold concentration (% injection dose/g, % ID/g).
Statistical analysis
Error bars are reported as mean ± s.d. The differences between groups were compared by analysis of Student's t-test and One-way ANOVA with the result shown in Fig. 4 , Supplementary Fig. 3 , Fig. 5 . P-value <0.05 was considered to be statistically significant. ns (no significant), *P<0.05 (significant), **P<0.005 (highly significant). Investigators conducting the experiments were not blinded. Dixon's Q test is used for identification and rejection of outliers in data analysis.
Data availability
The data that support the plots within this paper and other findings of the study are available from the corresponding author upon reasonable request. a, Whole-body X-ray images of the mice after being intravenously injected with Au 10-11 , Au 18 and Au 25 , respectively at 40 min post injection. While all three different AuNCs were cleared through the kidneys into the bladder, the smallest Au 10-11 has much longer kidney retention than Au 18 , which in turn has longer kidney retention than Au 25 even though there is only a 7-atom difference among these three AuNCs. b, The X-ray intensity bladder to kidney ratios of Au [10] [11] 12 , an important component of renal filtration, is composed of kidney blood vessel, glomerular filtration membrane and Bowman's space. The glomerular filtration membrane is composed of multiple layers: endothelial glycocalyx, endothelial cell, glomerular basement membrane (GBM) and podocyte. Podocytes are covered by 200 nm glycocalyx. Generally, the fenestration between endothelial cells is 70-90 nm; GBM junction is 2-8 nm; the sizes of podocyte slits are in the range of 4-11 nm (These numbers are measured in rat kidney but very similar to those found in human kidneys, Supplementary Table 1 ). Combination of these layers, the size threshold for kidney filtration is ~6 nm: NPs or proteins with a hydrodynamic diameter (HD) <6 nm can pass through glomerular filtration membrane readily while it is difficult for the large ones to cross through it. a, The GFM of the mouse injected with no particle, only PBS. No any NPs were observed from control glomeruli. b, The GFM of the mice at 10 min post injection of Au 25 , only few large silver-enhanced Au 25 were found in the glomeruli of the mouse. c, The GFM of the mouse at 10 min post injection of Au 18 , a large number of monodispersed silver-enhanced Au 18 were observed, which mainly bound to the glycocalyx of endothelial cells, glomerular basement membrane (GBM) as well as podocytes. d, Comparison between the glomerular filtration of these sub-nm AuNCs and size exclusive/gel filtration chromatography. Au 18 was more easily retained by the glycocalyx than Au 25 , as a result, Au 25 was filtrated much faster than Au 18 during the same time of period, very similar to the separation in the size exclusive/gel filtration chromatography, where larger molecules/particles will be filtrated faster than smaller ones because the smaller ones are physically retained by the stationary phase for a longer period. 25 . Although all the clusters show two-compartment pharmacokinetics, they exhibit distinct distribution and elimination half-lives even though there are only few-atom differences among these clusters (n=3, mean ± s.d.). e, Correlation of the number of gold atoms in the clusters with their retention in the plasma at 2 min. p.i., and their volume distribution (Vd) derived from pharmacokinetics measurements, showing that the blood retention was linearly decreased but the Vd of AuNCs linearly increased with the increase of the number of gold atoms. f, Correlation of elimination half-life and clearance (CL) of few-atom AuNCs with the number of gold atoms, showing that clearance exponentially increases but elimination half-life exponentially decreased with the increase of the number of gold atoms in the clusters. . These tumour/blood ratios of all the sub-nm AuNCs are all larger than 1 and much higher than muscle/blood ratios, showing that the selective accumulation of sub-nm AuNCs in tumour is fundamentally due to enhanced permeability and retention (EPR) effect. d, The distribution of Au 18 and Au 25 in MCF-7 tumour at 24 h p.i. Major tumour vasculatures were indicated with red arrows. Silver-stained Au 18 and Au 25 were indicated with yellow triangles. Nucleus and cytoplasm were stained by H&E. Scale bar is 50 μm. These images clearly showed that more Au 18 were accumulated in tumour microenvironment and vasculatures than Au 25 . e, Ratios of liver/blood, spleen/blood, intestine/blood and kidney/ blood for Au [10] [11] , Au 15 , Au 18 and Au 25 at 24 h p.i (n=3, mean ± s.d.). f, The accumulation of Au [10] [11] , Au 15 , Au 18 and Au 25 in the major organs in the body includes: brain, stomach, intestine, heart, spleen, lung, liver and kidney at 12 h, 7 days and 1 month p.i. (n=3, mean ± s.d.).
